Can f 1 Knockout Dogs (Kindred Companion Sciences)

A dated reading of what is claimed, reported, and independently verified in the current evidence.

Current reading

Readiness band and full integer triple

AI-assisted assembly · derived results

Readiness band

Emerging

Primary summary from verified readiness

Evidence strength Strong

Decision

Human editorial judgment · 2026-08-20

Too early to adopt

Why: The mechanism is real and the paper is genuinely peer-reviewed and indexed (PMID 42554239), but there is nothing to adopt: the vendor itself states the dogs are investigational and not commercially available, the human-efficacy evidence is one sensitized subject who appears to be the founder, only one of several dog allergens is removed, the animals are two clones from a one-employee company, and the off-target and health claims are company-reported behind a paywall that Europe PMC confirms is not open access.
Next: Re-check at the next quarterly refresh for (a) an FDA CVM intentional-genomic-alteration filing or approval, (b) any multi-subject skin-prick/IgE or basophil-activation cohort beyond the single sensitized subject, (c) evidence of a germline-bred (non-SCNT) line or a second breed, and (d) an accessible full text or preprint that lets the off-target and method claims be independently checked.

Constraints

No named blocker is present in the current public projection.

Evidence summary

AI-assisted assembly

Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.

Publication record

Initial public reading